Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Investigation
|
October 19, 2004
Superoxide production by phagocytic leukocytes: the scientific legacy of Bernard Babior
John T Curnutte
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2014
Pillars article: Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973. 52: 741-744
Bernard M Babior, Ruby S Kipnes, John T Curnutte
Current Opinion in Immunology
|
September 23, 2003
Chronic granulomatous disease
Paul G Heyworth, Andrew R Cross, John T Curnutte
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
Recurrent streptococcal hepatic abscesses in a 46-year-old woman
Robert Lo, Julie Rae, Deborah Noack, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 14, 2020
Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
Genmin Lu, Joyce Lin, Khanh Bui, et al.
Clinical Immunology (Orlando, Fla.)
|
December 25, 2002
Diminished T cell numbers in patients with chronic granulomatous disease
Meredith Heltzer, Abbas F Jawad, Julie Rae, et al.
Clinical Immunology (Orlando, Fla.)
|
July 16, 2008
Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease
Grace Yu, David K Hong, Kira Y Dionis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 4, 2004
Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease
Jeannie S Huang, Deborah Noack, Julie Rae, et al.
Blood Advances
|
February 25, 2020
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers
Genmin Lu, Pamela B Conley, Janet M Leeds, et al.
Plos One
|
March 29, 2018
Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model
Genmin Lu, Polly Pine, Janet M Leeds, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Investigation
|
October 19, 2004
Superoxide production by phagocytic leukocytes: the scientific legacy of Bernard Babior
John T Curnutte
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2014
Pillars article: Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973. 52: 741-744
Bernard M Babior, Ruby S Kipnes, John T Curnutte
Current Opinion in Immunology
|
September 23, 2003
Chronic granulomatous disease
Paul G Heyworth, Andrew R Cross, John T Curnutte
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
Recurrent streptococcal hepatic abscesses in a 46-year-old woman
Robert Lo, Julie Rae, Deborah Noack, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 14, 2020
Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
Genmin Lu, Joyce Lin, Khanh Bui, et al.
Clinical Immunology (Orlando, Fla.)
|
December 25, 2002
Diminished T cell numbers in patients with chronic granulomatous disease
Meredith Heltzer, Abbas F Jawad, Julie Rae, et al.
Clinical Immunology (Orlando, Fla.)
|
July 16, 2008
Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease
Grace Yu, David K Hong, Kira Y Dionis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 4, 2004
Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease
Jeannie S Huang, Deborah Noack, Julie Rae, et al.
Blood Advances
|
February 25, 2020
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers
Genmin Lu, Pamela B Conley, Janet M Leeds, et al.
Plos One
|
March 29, 2018
Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model
Genmin Lu, Polly Pine, Janet M Leeds, et al.
Page
of 2